84 related articles for article (PubMed ID: 31138789)
21. Significance of metallothionein expression in liver disease.
Nagamine T; Nakajima K
Curr Pharm Biotechnol; 2013; 14(4):420-6. PubMed ID: 23590140
[TBL] [Abstract][Full Text] [Related]
22. Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview.
Charidemou E; Koufaris C; Louca M; Kirmizis A; Rubio-Tomás T
Clin Transl Oncol; 2023 Jun; 25(6):1594-1605. PubMed ID: 36650321
[TBL] [Abstract][Full Text] [Related]
23. ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma.
Wu YJ; Ko BS; Liang SM; Lu YJ; Jan YJ; Jiang SS; Shyue SK; Chen L; Liou JY
Cell Death Dis; 2019 May; 10(6):408. PubMed ID: 31138789
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of 14-3-3ε, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma.
Wu CY; Jan YJ; Ko BS; Wu YJ; Wu YJ; Liou JY
Anticancer Res; 2018 Dec; 38(12):6855-6863. PubMed ID: 30504401
[TBL] [Abstract][Full Text] [Related]
25. HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma.
Zhao Z; Hu Y; Shen X; Lao Y; Zhang L; Qiu X; Hu J; Gong P; Cui H; Lu S; Zheng Y; Zhou M; Fan H
Oncol Rep; 2017 May; 37(5):2811-2818. PubMed ID: 28339081
[TBL] [Abstract][Full Text] [Related]
26. Transcription factor LSF-DNMT1 complex dissociation by FQI1 leads to aberrant DNA methylation and gene expression.
Chin HG; Ponnaluri VK; Zhang G; Estève PO; Schaus SE; Hansen U; Pradhan S
Oncotarget; 2016 Dec; 7(50):83627-83640. PubMed ID: 27845898
[TBL] [Abstract][Full Text] [Related]
27. The novel mTOR inhibitor Torin-2 induces autophagy and downregulates the expression of UHRF1 to suppress hepatocarcinoma cell growth.
Wang C; Wang X; Su Z; Fei H; Liu X; Pan Q
Oncol Rep; 2015 Oct; 34(4):1708-16. PubMed ID: 26239364
[TBL] [Abstract][Full Text] [Related]
28. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
29. KRAB zinc finger proteins.
Ecco G; Imbeault M; Trono D
Development; 2017 Aug; 144(15):2719-2729. PubMed ID: 28765213
[TBL] [Abstract][Full Text] [Related]
30. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.
Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D
Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737
[TBL] [Abstract][Full Text] [Related]
31. The SUMO-specific isopeptidase SENP3 regulates MLL1/MLL2 methyltransferase complexes and controls osteogenic differentiation.
Nayak A; Viale-Bouroncle S; Morsczeck C; Muller S
Mol Cell; 2014 Jul; 55(1):47-58. PubMed ID: 24930734
[TBL] [Abstract][Full Text] [Related]
32. 14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma.
Liu CC; Jan YJ; Ko BS; Wu YM; Liang SM; Chen SC; Lee YM; Liu TA; Chang TC; Wang J; Shyue SK; Sung LY; Liou JY
BMC Cancer; 2014 Jun; 14():425. PubMed ID: 24923353
[TBL] [Abstract][Full Text] [Related]
33. MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma.
Ji XF; Fan YC; Gao S; Yang Y; Zhang JJ; Wang K
World J Gastroenterol; 2014 Apr; 20(16):4723-9. PubMed ID: 24782625
[TBL] [Abstract][Full Text] [Related]
34. Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription.
Xu B; Li SH; Zheng R; Gao SB; Ding LH; Yin ZY; Lin X; Feng ZJ; Zhang S; Wang XM; Jin GH
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17480-5. PubMed ID: 24101467
[TBL] [Abstract][Full Text] [Related]
35. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
[TBL] [Abstract][Full Text] [Related]
36. αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma.
Huang XY; Ke AW; Shi GM; Zhang X; Zhang C; Shi YH; Wang XY; Ding ZB; Xiao YS; Yan J; Qiu SJ; Fan J; Zhou J
Hepatology; 2013 Jun; 57(6):2235-47. PubMed ID: 23316005
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
